Armenian central bank approves new version of Ameriabank’s

YEREVAN, June 29. /ARKA/. The Central Bank of Armenia has approved a new version of Ameriabank’s charter and voided Cascade Bank CJSC’s license because of the merger of these two banks, the central bank’s press office reported on Monday.

The regulator registered the merger of Ameriabank and Cascade Bank on June 18. -0—

spot_img

POPULAR

Record growth of Armenia’s reserves to $6.9 billion in June provided a buffer amid heightened geopolitical risks – S&P

Armenia's international reserves increased by approximately 40% year-on-year to a record $6.9 billion in June 2026, helping to strengthen the country's external reserves despite heightened geopolitical risks, according to a report by international rating agency S&P Global Ratings.

S&P affirms Armenia’s ratings, maintaining a positive outlook

The international rating agency S&P Global Ratings affirmed the long- and short-term sovereign ratings of the Republic of Armenia at 'BB-/B', maintaining a positive outlook, the Ministry of Finance reported.

Armbanks Weekly Digest: Key Events in the Armenian Financial Market (August 17–23)

Key developments in Armenia's financial market this week included new banking compliance requirements, measures against account fraud, and decisions related to capital market development.

Armenian banks’ investments in securities in the second quarter amounted to 1.92 trillion drams

The total volume of investments by Armenian commercial banks in securities as of the end of June 2026 amounted to 1,922,826,829 thousand drams.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img